newsfilter
← Latest News
PR Newswire·

Oramed to Host Key Opinion Leader Webinar on Need for Oral Insulin in Type 2 Diabetes

NEW YORK, March 22, 2022 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced that it will host a web